• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MDM2 SNP309T>G 多态性与肝细胞癌风险的关系:一项荟萃分析。

MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis.

机构信息

The State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China.

出版信息

Arch Med Res. 2011 Feb;42(2):149-55. doi: 10.1016/j.arcmed.2011.02.002.

DOI:10.1016/j.arcmed.2011.02.002
PMID:21565629
Abstract

BACKGROUND AND AIMS

The murine double minute 2 (MDM2) gene encodes a negative regulator of the tumor protein p53. A single nucleotide polymorphism (SNP) in MDM2 promoter, SNP309 T>G, has been reported to alter MDM2 protein expression and accelerate tumor formation in humans. Studies investigating the association between the polymorphism and human hepatocellular carcinoma (HCC) risk reported conflicting results. We performed a meta-analysis to explore the association of this polymorphism and HCC risk.

METHODS

All eligible studies published were searched for in PubMed. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were assessed for the association using fixed- and random-effects models.

RESULTS

We identified five case-control studies including 738 cases and 1014 controls for the present meta-analysis. In studies with limited data, we detected significant associations for all genetic models in the overall analysis (OR = 2.51, 95% CI = 1.88-3.36 for GG vs. TT, p <0.001, P(het) = 0.666; OR = 1.71, 95% CI = 1.35-2.18 for TG vs. TT, p <0.001, P(het) = 0.925; OR = 1.94, 95% CI = 1.54-2.43 for dominant model TG + GG vs. TT, p <0.001, P(het) = 0.772; OR = 1.74, 95% CI = 1.39-2.20 for recessive model GG vs. TT + TG, p <0.001, P(het) = 0.656). Moreover, in the subgroup analysis based on Hardy-Weinberg equilibrium (HWE) in controls, sample size, and ethnicity, significant associations were observed in most genetic models.

CONCLUSIONS

This meta-analysis suggests that the MDM2 309 G allele probably acts as an important HCC risk factor. To further confirm our findings, well-designed studies with large sample sizes and representing different ethnicities are required.

摘要

背景与目的

鼠双微体 2(MDM2)基因编码肿瘤蛋白 p53 的负调控因子。已报道 MDM2 启动子中的单核苷酸多态性(SNP)SNP309T>G 改变 MDM2 蛋白表达并加速人类肿瘤形成。研究该多态性与人类肝细胞癌(HCC)风险之间的关联的研究报告结果相互矛盾。我们进行了荟萃分析以探讨该多态性与 HCC 风险的关联。

方法

在 PubMed 中搜索所有已发表的符合条件的研究。使用固定效应模型和随机效应模型评估关联的粗比值比(OR)和 95%置信区间(CI)。

结果

我们确定了五项病例对照研究,其中包括 738 例病例和 1014 例对照,进行了本次荟萃分析。在数据有限的研究中,我们在总体分析中检测到所有遗传模型均有显著关联(OR=2.51,95%CI=1.88-3.36,GG 与 TT 相比,p<0.001,P(het)=0.666;OR=1.71,95%CI=1.35-2.18,TG 与 TT 相比,p<0.001,P(het)=0.925;OR=1.94,95%CI=1.54-2.43,显性模型 TG+GG 与 TT 相比,p<0.001,P(het)=0.772;OR=1.74,95%CI=1.39-2.20,隐性模型 GG 与 TT+TG 相比,p<0.001,P(het)=0.656)。此外,在基于对照组 Hardy-Weinberg 平衡(HWE)、样本量和种族的亚组分析中,大多数遗传模型均观察到显著关联。

结论

本荟萃分析表明,MDM2 309G 等位基因可能是 HCC 的重要危险因素。为了进一步证实我们的发现,需要设计良好的、具有较大样本量和代表不同种族的研究。

相似文献

1
MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis.MDM2 SNP309T>G 多态性与肝细胞癌风险的关系:一项荟萃分析。
Arch Med Res. 2011 Feb;42(2):149-55. doi: 10.1016/j.arcmed.2011.02.002.
2
MDM2 SNP309T>G polymorphism and risk of hepatocellular carcinoma: a case-control analysis in a Moroccan population.MDM2基因SNP309T>G多态性与肝细胞癌风险:摩洛哥人群的病例对照分析
Cancer Detect Prev. 2009;32(5-6):380-5. doi: 10.1016/j.cdp.2009.01.003. Epub 2009 Feb 23.
3
MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.MDM2 启动子多态性与土耳其人群肝癌易感性增加相关。
Cancer Epidemiol. 2010 Aug;34(4):448-52. doi: 10.1016/j.canep.2010.04.008. Epub 2010 May 5.
4
MDM2 309T>G polymorphism and risk of squamous cell carcinomas of head and neck: a meta-analysis.MDM2基因309T>G多态性与头颈部鳞状细胞癌风险:一项荟萃分析。
Asian Pac J Cancer Prev. 2011;12(8):1899-903.
5
Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.p53密码子72与MDM2 309T>G多态性之间的相互作用及肝细胞癌风险
Tumour Biol. 2016 Mar;37(3):3863-70. doi: 10.1007/s13277-015-4222-4. Epub 2015 Oct 17.
6
The MDM2 309 T/G polymorphism is associated with head and neck cancer risk especially in nasopharyngeal cancer: a meta-analysis.MDM2基因309位点T/G多态性与头颈癌风险相关,尤其是在鼻咽癌中:一项荟萃分析。
Onkologie. 2012;35(11):666-70. doi: 10.1159/000343639. Epub 2012 Oct 22.
7
An updated meta-analysis on the association of MDM2 SNP309 polymorphism with colorectal cancer risk.MDM2 SNP309 多态性与结直肠癌风险关联的更新荟萃分析。
PLoS One. 2013 Sep 30;8(9):e76031. doi: 10.1371/journal.pone.0076031. eCollection 2013.
8
TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.TP53和MDM2基因多态性、基因-基因相互作用与肝细胞癌风险:一项更新的荟萃分析证据
PLoS One. 2013 Dec 23;8(12):e82773. doi: 10.1371/journal.pone.0082773. eCollection 2013.
9
The MDM2 SNP309T>G polymorphism increases bladder cancer risk among Caucasians: a meta-analysis.MDM2基因SNP309T>G多态性增加白种人患膀胱癌的风险:一项荟萃分析。
Asian Pac J Cancer Prev. 2014;15(13):5277-81. doi: 10.7314/apjcp.2014.15.13.5277.
10
MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis.MDM2基因SNP309多态性与子宫内膜癌易感性相关:一项荟萃分析的证据
J Exp Clin Cancer Res. 2013 Nov 3;32(1):85. doi: 10.1186/1756-9966-32-85.

引用本文的文献

1
Association of rs2279744 and rs117039649 promoter polymorphism with the risk of gynecological cancer: A meta-analysis of case-control studies.rs2279744和rs117039649启动子多态性与妇科癌症风险的关联:病例对照研究的荟萃分析
Medicine (Baltimore). 2018 Jan;97(2):e9554. doi: 10.1097/MD.0000000000009554.
2
Systematic analyses and comprehensive field synopsis of genetic association studies in hepatocellular carcinoma.肝细胞癌基因关联研究的系统分析与综合领域概述
Oncotarget. 2016 Jul 19;7(29):45757-45763. doi: 10.18632/oncotarget.9937.
3
Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.
乙型肝炎病毒相关肝细胞癌中的宿主核苷酸多态性。
World J Hepatol. 2016 Apr 8;8(10):485-98. doi: 10.4254/wjh.v8.i10.485.
4
Human genetic variation and the risk of hepatocellular carcinoma development.人类遗传变异与肝细胞癌发生风险
Hepatol Int. 2013 Jul;7(3):820-31. doi: 10.1007/s12072-013-9463-y. Epub 2013 Aug 2.
5
MDM2 SNP309 variation confers the susceptibility to hepatocellular cancer: a meta-analysis based on 4271 subjects.MDM2基因SNP309变异与肝细胞癌易感性的关系:基于4271例受试者的Meta分析
Int J Clin Exp Med. 2015 Apr 15;8(4):5822-30. eCollection 2015.
6
Lack of association of the TP53BP1 Glu353Asp polymorphism with risk of cancer: a systematic review and meta-analysis.TP53BP1基因Glu353Asp多态性与癌症风险无关:一项系统评价和荟萃分析。
PLoS One. 2014 Mar 6;9(3):e90931. doi: 10.1371/journal.pone.0090931. eCollection 2014.
7
MDM2 SNP309T>G polymorphism and hepatocellular carcinoma risk: a meta-analysis.MDM2基因SNP309T>G多态性与肝细胞癌风险:一项荟萃分析
Tumour Biol. 2014 May;35(5):4147-51. doi: 10.1007/s13277-013-1543-z. Epub 2013 Dec 31.
8
Ewing Sarcoma: influence of TP53 Arg72Pro and MDM2 T309G SNPs.尤因肉瘤:TP53 Arg72Pro 和 MDM2 T309G SNP 的影响。
Mol Biol Rep. 2013 Aug;40(8):4929-34. doi: 10.1007/s11033-013-2593-4. Epub 2013 May 10.
9
The glutathione S-transferase P1 341C>T polymorphism and cancer risk: a meta-analysis of 28 case-control studies.谷胱甘肽 S-转移酶 P1 341C>T 多态性与癌症风险:28 项病例对照研究的荟萃分析。
PLoS One. 2013;8(2):e56722. doi: 10.1371/journal.pone.0056722. Epub 2013 Feb 21.
10
The MDM2 309T>G polymorphism and ovarian cancer risk: a meta-analysis of 1534 cases and 2211 controls.MDM2 309T>G 多态性与卵巢癌风险:1534 例病例和 2211 例对照的荟萃分析。
PLoS One. 2013;8(1):e55019. doi: 10.1371/journal.pone.0055019. Epub 2013 Jan 31.